FrontPage logo

FrontPage

exit_to_appLogin
FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors
Signup
Frontpage iOS AppFrontpage Android App
forum

GUFICBIO Share Price Discussion

Gufic BioSciences Ltd.
Sector: Pharmaceuticals and health care
... Read more
GUFICBIO Share Price *
62.25 -2.05 (-3.19%)
* (quote may be delayed)

Find answers to all your questions on live GUFICBIO message board: Is GUFICBIO buy or sell? Should I buy GUFICBIO shares? Why are GUFICBIO shares falling? Should I invest in GUFICBIO stock?


GUFICBIO Discussion Forum

NewsBot @newsbot
 in 
GUFICBIO
•
Oct 4 2:38 AM
Miracle aging treatment Botox set to face fight from this little-known Indian firm
BSE-listed Gulfic Biosciences has received approvals to manufacture and sell Botulinum toxin, better known by popular brand name Botox.
Moneycontrol

https://www.moneycontrol.com/news/business/companies/mira...
Like
reply
Reply
share
Share
  • GUFICBIO - Share Price - Fundamentals

    keyboard_arrow_down
    Market Capitalization837.86
    Enterprise Value910.45
    Price to Earnings52.3
    Price to Book Value15.66
    Return on Capital Employed0.29
    Return on Equity0.3
    Face Value1
    Dividend YieldNA
  • GUFICBIO Share Price - Technicals

    keyboard_arrow_down
    GUFICBIO - 52 Week High₹99.1
    GUFICBIO - 52 Week Low₹51.05
  • GUFICBIO Share Price - Historical (₹)

    keyboard_arrow_down
    DateOpenHighLowClose
    Dec 664.364.962.0562.45
    Dec 565.4566.464.0564.3
    Dec 467.8567.8564.465.4
    Dec 369.370.867.1567.7
    Dec 269.4570.26868.3
  • GUFICBIO Share Price - Daily Moving Averages (DMA)

    keyboard_arrow_down
    20 Day Moving Average₹67.32
    30 Day Moving Average₹68.38
    50 Day Moving Average₹69.35
    100 Day Moving Average₹66.32
    200 Day Moving Average₹71.68
  • GUFICBIO - Profit And Loss

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Revenue300.96249.270.21
    Operating Profit38.1626.970.41
    Profit Before Tax29.5418.020.64
    Net Income16.0211.410.4
  • GUFICBIO - Balance Sheet

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Shareholder's Funds53.5244.910.19
    Total Liabilities182.55134.410.36
    Total Assets236.07179.320.32
  • GUFICBIO - Cash Flow

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Cash from Operating Activity-4.85-4.40.1
    Cash from Investing Activity-8.84-3.321.66
    Cash from Financing Activity14.497.091.04
    Net Cash Flow0.8-0.63-2.27
  • GUFICBIO - Ratios

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17
    Return on Assets0.070.06
    Return on Equity0.30.25
    Return on Capital Employed0.290.24
  • GUFICBIO - 3 year Growth

    keyboard_arrow_down
    3 Year CAGR Growth in Revenue0.99
    3 Year CAGR Growth in Operating Profit1.67
    3 Year CAGR Growth in EBIDTA1.88
    3 Year CAGR Growth in Net Income2.85
    3 Yr CAGR Growth - Diluted EPS2.83
  • GUFICBIO - 5 year Growth

    keyboard_arrow_down
    5 Year CAGR Growth in Revenue2.01
    5 Year CAGR Growth in Operating Profit2.55
    5 Year CAGR Growth in EBIDTA2.84
    5 Year CAGR Growth in Net Income3.81
    3 Yr CAGR Growth - Diluted EPS3.81
  • GUFICBIO - Recent News

    keyboard_arrow_down
    NewsBot
    Oct 4 2:38 AM
    Miracle aging treatment Botox set to face fight from this little-known Indian firm
    Moneycontrol
  • GUFICBIO - Related Communities

    keyboard_arrow_down
    WANBURY
    Wanbury Ltd. Sector: Pharmaceuticals ...
    PIRPHYTO
    Piramal Phytocare Ltd. Sector: Pharma...
    PARABDRUGS
    Parabolic Drugs Ltd. Sector: Pharmace...
    ORCHIDPHAR
    Orchid Pharma Ltd. Sector: Pharmaceut...
    BIOFILCHEM
    Biofil Chemicals & Pharmaceuticals Lt...
    WOCKPHARMA
    Wockhardt Ltd. Sector: Pharmaceutical...
    VIVIMEDLAB
    Vivimed Labs Ltd. Sector: Pharmaceuti...
    VENUSREM
    Venus Remedies Ltd. Sector: Pharmaceu...
    UNICHEMLAB
    Unichem Laboratories Ltd. Sector: Pha...
    TTKHLTCARE
    TTK Healthcare Ltd. Sector: Pharmaceu...
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

FrontPage Apps
Frontpage iOS AppFrontpage Android App
HelpAboutPrivacyTermsDisclaimersRefunds